MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Cassava Sciences Inc

Suletud

SektorTervishoid

1.36 -9.93

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.35

Max

1.46

Põhinäitajad

By Trading Economics

Sissetulek

346K

-28M

Aktsiakasum

-0.57

Töötajad

30

EBITDA

1.4M

-30M

Soovitused

By TipRanks

Soovitused

Müü

12 kuu keskmine prognoos

+33.33% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

8. mai 2025

Turustatistika

By TradingEconomics

Turukapital

-40M

80M

Eelmine avamishind

11.29

Eelmine sulgemishind

1.36

Uudiste sentiment

By Acuity

100%

0%

370 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

Cassava Sciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

27. sept 2024, 10:48 UTC

Suurimad hinnamuutused turgudel

Cassava Sciences Shares Lower Premarket on $40 Million Penalty to Settle Doctored Data Claims

28. juuni 2024, 20:15 UTC

Suurimad hinnamuutused turgudel

Cassava Sciences' Shares Down 46% After Adviser Is Indicted

27. sept 2024, 18:36 UTC

Tulu

These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava, DJT, Wynn, HP Inc., Acadia Healthcare, and More -- Barrons.com

27. sept 2024, 09:15 UTC

Kuumad aktsiad

Stocks to Watch Friday: Bristol Myers Squibb, EchoStar, Costco -- WSJ

Võrdlus sarnastega

Hinnamuutus

Cassava Sciences Inc Prognoos

Hinnasiht

By TipRanks

33.33% tõus

12 kuu keskmine prognoos

Keskmine 2 USD  33.33%

Kõrge 2 USD

Madal 2 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Cassava Sciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Müü

2 ratings

0

Osta

1

Hoia

1

Müü

Tehniline skoor

By Trading Central

N/A / 1.75Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Neutral Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

370 / 386 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.